Cantor Fitzgerald analyst Kristen Kluska maintained a Buy rating on 89bio (ETNB – Research Report) today and set a price target of $29.00. The ...

Cantor Fitzgerald restated their overweight rating on shares of Celldex Therapeutics (NASDAQ:CLDX – Free Report) in a ...

Cantor Fitzgerald lowered their FY2024 EPS estimates for shares of CVS Health in a report issued on Tuesday, December 31st.

Cantor Fitzgerald raised the firm’s price target on Axsome Therapeutics (AXSM) to $124 from $121 and keeps an Overweight rating on the shares ...

CJ Muse, Cantor Fitzgerald analyst, joins 'Squawk on the Street' to discuss the latest news regarding Qualcomm, if it's still ...

Poseida Therapeutics Inc (PSTX) stock saw a decline, ending the day at $9.4 which represents a decrease of $-0.20 or -2.08% from the prior close of $9.6. The stock opened at $9.54 and touched a low of ...

Cantor Fitzgerald has recently initiated ARS Pharmaceuticals Inc (SPRY) stock to Overweight rating, as announced on August 20, 2024, according to Finviz. Earlier, on August 13, 2024, Raymond James had ...

https://www.tipranks.com/news/the-fly/cantor-fitzgerald-bullish-on-avita-medical-after-fda-approval-for-recell-go-mini Cantor Fitzgerald reiterates an Overweight ...

On that date, Aquila announced separate agreements with New York Life and Cantor Fitzgerald to sell its investment advisory business. Pending the expected completion of those transactions in July ...

The Securities and Exchange Commission (SEC) on Thursday charged Cantor Fitzgerald L.P., a global financial services firm headed by one ...

Global Petroleum PLC has announced a change in its voting rights structure, with Cantor Fitzgerald Europe acquiring a significant stake. This acquisition raises Cantor Fitzgerald’s voting rights ...

Cantor Fitzgerald reiterates an Overweight rating on Avita Medical (RCEL) following the company receiving FDA premarket approval for RECELL GO Mini, its miniaturized device designed to treat ...